Akouos Inc (AKUS) Stock

DelistedNasdaq: AKUSAkouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals.

13.29
Final close · Nov 30, 2022

AKUS is no longer traded. Akouos Inc was delisted from the Nasdaq in November 2022.

Prices on this page are historical; the last trade was November 30, 2022 at $13.29.

Akouos Inc stock price history

Split-adjusted closes, 2020–2022

AKUS final trading statistics

Final close
$13.29
Final trading day
Nov 30, 2022
Market cap at delisting
$491.01M
Shares outstanding
36.95M
Final 52-week range
$2.31 – $13.60
Avg. volume (final 3 mo.)
683,658
All-time high (split-adj.)
$26.92 · Sep 2020
All-time low (split-adj.)
$2.46 · May 2022
Return since IPO
-39.6%
Beta
-0.56
Book value / share
$4.90
Price / book
2.71
Final 52 wk
2.3113.60

Akouos Inc earnings per share

Earnings per share

Akouos Inc revenue & net income

RevenueNet income

Akouos Inc annual financials

Akouos Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2021$0.00-$86.7M-$2.52
FY2020$0.00-$48.6M-$27.09
FY2019$0.00-$25.7M—
FY2018$0.00-$6.0M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Akouos Inc

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Akouos Inc stock FAQ

What happened to Akouos Inc stock?

Akouos Inc stock was delisted from the Nasdaq. Its final close was $13.29 on November 30, 2022.

Is AKUS stock still trading?

No. AKUS was delisted from the Nasdaq in November 2022 and no longer trades on a U.S. exchange.

What was the last price of AKUS stock?

AKUS closed at $13.29 on its final trading day, November 30, 2022, for a market value of about $491.01M.

What were Akouos Inc's revenue and earnings in its last full fiscal year?

Akouos Inc reported revenue of $0.00 and net income of -$86.7M in fiscal 2021, its last full year as a public company.

When did Akouos Inc go public?

Akouos Inc stock began trading on June 26, 2020.

Biotechnology stocks to research

All Healthcare stocks →